Clinical trials for Medullary sponge kidney
32 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07489131Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular EdemaAlvotech Swiss AG
- RECRUITINGPhase 2NCT07441642A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationNovartis Pharmaceuticals
- ENROLLING BY INVITATIONPhase 2NCT07395986A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related CataractOcusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
- RECRUITINGPhase 2NCT07400965Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex BlepharitisGlaukos Corporation · PI: Study Director, MD
- RECRUITINGPhase 3NCT07235085A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic RetinopathyOcular Therapeutix, Inc. · PI: Allen Hu, MD
- RECRUITINGPhase 2NCT07128628A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye DiseaseBausch & Lomb Incorporated
- RECRUITINGPhase 3NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAKKodiak Sciences Inc · PI: Pablo Velazquez-Martin, MD
- RECRUITINGPhase 3NCT07064759Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration4D Molecular Therapeutics · PI: Julie Tsai, MD
- RECRUITINGPhase 3NCT06996080A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLEKodiak Sciences Inc
- RECRUITINGPhase 2NCT07215390A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular DegeneratioApellis Pharmaceuticals, Inc.
- RECRUITINGN/ANCT07021560Wearability of and Myopia Progression With ZEISS MyoCare Spectacle LensesZEISS Vision Care · PI: Chi Hoang Viet Vu, MD
- RECRUITINGPhase 3NCT06911424Efficacy of Fusidic Acid 1% in the Treatment of Bacterial ConjunctivitisBaxis Pharmaceuticals, Inc.
- ACTIVE NOT RECRUITINGPhase 3NCT068649884D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration4D Molecular Therapeutics · PI: Hersh Patel
- RECRUITINGPhase 2NCT07058688A Study of NTRX-07 in Participants With Alzheimer's DiseaseNeuroTherapia, Inc. · PI: Joseph F Foss, MD
- ACTIVE NOT RECRUITINGN/ANCT07367204Randomized Masked Trial of Injectable Cross-Linked Hyaluronic Acid for Moderate-to-Severe Nasolabial FoldsChongqing Jinsaixing Medical Technology Co., Ltd
- RECRUITINGPhase 2NCT06770933A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01Vantage Biosciences Ltd
- RECRUITINGPhase 2NCT06543303Evaluation of BTV100 in Subjects With Dry Eye DiseaseBioTheraVision, Inc. · PI: Mulan Lee, PhD
- RECRUITINGPhase 3NCT06666855A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in ChinaSanten Pharmaceutical Co., Ltd.
- RECRUITINGN/ANCT06685107Virtual Reality and Standard Care vs. Standard Care Alone for Acute MSK Pain in Geriatric ED PatientsAntonios Likourezos · PI: Sergey Motov, MD
- RECRUITINGPhase 2NCT06686472Evaluation of TL-925 for the Treatment of Allergic ConjunctivitisTelios Pharma, Inc.
- ACTIVE NOT RECRUITINGN/ANCT06577948The P.A.U.S.E.® Spectacle Studynthalmic Pty Ltd · PI: Daniel Tilia, MOptom, PhD
- ACTIVE NOT RECRUITINGPhase 3NCT06625411An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)Viridian Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPhase 3NCT06625398An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)Viridian Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPhase 4NCT06565650A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.Bausch & Lomb Incorporated
- RECRUITINGN/ANCT06313749Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite PolypharmacySanoculis Ltd
- ACTIVE NOT RECRUITINGPhase 3NCT06373731ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)Stealth BioTherapeutics Inc. · PI: Rekha Sathyanarayana
- ACTIVE NOT RECRUITINGPhase 2NCT06116890Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular DegenerationKyowa Kirin Co., Ltd. · PI: Sotaro Takigawa
- ACTIVE NOT RECRUITINGPhase 2NCT059305614D-150 in Patients With Diabetic Macular Edema4D Molecular Therapeutics · PI: Julie Clark, MD
- RECRUITINGN/ANCT05914922Wadey RCT MSK Short Case Simulations With FMEDSunnybrook Health Sciences Centre · PI: Veronica M Wadey, MD,MA
- ACTIVE NOT RECRUITINGN/ANCT05237401Non-surgical vs. Surgical Therapy for Periodontal FurcationsKing's College London · PI: Luigi Nibali
- ACTIVE NOT RECRUITINGPhase 3NCT04657289A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)Hoffmann-La Roche · PI: Clinical Trials
- ACTIVE NOT RECRUITINGPhase 2NCT04577300Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for GlaucomaStanford University · PI: Jeffrey L Goldberg, MD, PhD